PORTACCIO, EMILIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.770
EU - Europa 5.481
AS - Asia 1.257
AF - Africa 35
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 3
Totale 16.557
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.753
RU - Federazione Russa 1.745
PL - Polonia 1.308
IT - Italia 767
IE - Irlanda 526
SE - Svezia 522
SG - Singapore 396
CN - Cina 267
HK - Hong Kong 266
UA - Ucraina 140
FI - Finlandia 132
DE - Germania 129
IN - India 100
GB - Regno Unito 73
TR - Turchia 66
JO - Giordania 53
KR - Corea 40
CH - Svizzera 31
VN - Vietnam 30
FR - Francia 28
CI - Costa d'Avorio 20
CA - Canada 15
BE - Belgio 14
CZ - Repubblica Ceca 14
ES - Italia 14
NL - Olanda 13
IR - Iran 11
JP - Giappone 11
SC - Seychelles 11
MK - Macedonia 6
EU - Europa 5
BG - Bulgaria 4
BR - Brasile 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
DZ - Algeria 3
LT - Lituania 3
TH - Thailandia 3
AL - Albania 2
AZ - Azerbaigian 2
HU - Ungheria 2
NO - Norvegia 2
PH - Filippine 2
RS - Serbia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
CY - Cipro 1
EC - Ecuador 1
GE - Georgia 1
KW - Kuwait 1
LU - Lussemburgo 1
MX - Messico 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 16.557
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.358
Fairfield 1.310
Warsaw 1.308
Ashburn 595
Woodbridge 581
Dublin 526
Seattle 505
Chandler 502
Cambridge 500
Houston 464
Wilmington 398
Singapore 295
Altamura 225
Jacksonville 220
Lawrence 215
Ann Arbor 200
Princeton 152
Hong Kong 151
Beijing 133
Boston 90
Buffalo 89
Mumbai 86
Boardman 78
Florence 78
Medford 68
Moscow 63
San Diego 62
Izmir 49
Shanghai 48
Dearborn 43
Seoul 39
Kent 38
Milan 37
New York 34
Helsinki 30
Norwalk 28
Dong Ket 26
Bern 23
Yubileyny 23
Abidjan 20
Falls Church 19
Andover 16
London 16
Rome 16
Hillsboro 14
West Jordan 14
Barcelona 13
Brno 13
Brussels 13
Bari 11
Genoa 11
Toronto 11
Turin 10
Washington 10
Phoenix 9
Auburn Hills 8
Catania 8
Chennai 8
Frankfurt Am Main 8
Bologna 7
Bremen 7
L'aquila 7
Los Angeles 7
Salerno 7
Falkenstein 6
Montepulciano 6
Redmond 6
Saint Petersburg 6
Caserta 5
Chicago 5
Guangzhou 5
Laurel 5
Lucca 5
Padova 5
Pune 5
Redwood City 5
Campobasso 4
Chengdu 4
Formia 4
Ikejiri 4
Lausanne 4
Tehran 4
Verona 4
Algiers 3
Atlanta 3
Berlin 3
Dubai 3
Fiumicino 3
Hefei 3
Kunming 3
Mesagne 3
Nanjing 3
Naples 3
Napoli 3
Prescot 3
Raffadali 3
Romola 3
San Lazzaro Di Savena 3
Tappahannock 3
Wuhan 3
Totale 12.096
Salva come PNG Salva come JPEG
Nome #
The Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): normative values with gender, age and education corrections in the Italian population. 413
Improving the characterization of radiologically isolated syndrome suggestive of multiple sclerosis. 274
Increased CD8+ T cell responses to apoptotic T cell-associated antigens in multiple sclerosis. 255
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study. 255
EPIDURAL ANALGESIA AND CESAREAN DELIVERY IN MULTIPLE SCLEROSIS POST PARTU RELAPSES: THE ITALIAN COHORT STUDY. 243
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study. 239
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational study. 230
Relevance of brain lesion location to cognition in relapsing multiple sclerosis 227
Improvement on the Coma Recovery Scale–Revised During the First Four Weeks of Hospital Stay Predicts Outcome at Discharge in Intensive Rehabilitation After Severe Brain Injury 203
THE RAO'S BRIEF REPEATABLE BATTERY AND STROOP TEST: NORMATIVE VALUES WITH AGE, EDUCATION AND GENDER CORRECTIONS IN AN ITALIAN POPULATION. 185
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 181
Score on Coma Recovery Scale-Revised at admission predicts outcome at discharge in intensive rehabilitation after severe brain injury 177
Anxiety state affects information processing speed in patients with multiple sclerosis. 173
The Rao's Brief Repeatable Battery version B: normative values with age, education and gender corrections in an Italian population. 164
Appraisal of brain connectivity in radiologically isolated syndrome by modeling imaging measures. 164
Cognitive impairment in multiple sclerosis: An exploratory analysis of environmental and lifestyle risk factors 153
Prevalence of patient-reported dysphagia in multiple sclerosis patients: an Italian multicenter study (using the DYMUS questionnaire). 152
Pronounced Structural and Functional Damage in Early Adult Pediatric-Onset Multiple Sclerosis with No or Minimal Clinical Disability 148
Cognitive reserve and cortical atrophy in multiple sclerosis: a longitudinal study. 147
Critical illness-polyneuromyopathy: functional impact after severe Acquired Brain Injuries 146
Impact of cognitive impairment on coping strategies in multiple sclerosis. 145
Cognitive impairment and event-related potentials in paediatric multiple sclerosis: 2-year study. 145
Cognitive impairment in early stages of multiple sclerosis. 145
A short version of Rao's Brief Repeatable Battery as a screening tool for cognitive impairment in multiple sclerosis. 142
BRAIN DAMAGE AS DETECTED BY MAGNETIZATION TRANSFER IMAGING IS LESS PRONOUNCED IN BENIGN THAN IN EARLY RELAPSING MULTIPLE SCLEROSIS. 138
Computer-assisted rehabilitation of attention in patients with multiple sclerosis: results of a randomized, double-blind trial. 138
Association of MRI metrics and cognitive impairment in radiologically isolated syndromes. 138
Immunohistochemistry analysis of bone marrow biopsies in multiple sclerosis patients undergoing autologous haematopoietic stem cells transplantation 137
Decannulation and improvement of responsiveness in patients with disorders of consciousness 137
Changes in neuropsychological test performance over the workday in multiple sclerosis. 133
Cognitive rehabilitation in children and adolescents with multiple sclerosis. 130
Cognitive assessment and quantitative magnetic resonance metrics can help to identify benign multiple sclerosis. 129
Cognitive and psychosocial features in childhood and juvenile MS: two-year follow-up. 129
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes 128
Aging with multiple sclerosis: prevalence and profile of cognitive impairment 125
Patients with paediatric-onset multiple sclerosis are at higher risk of cognitive impairment in adulthood: An Italian collaborative study 125
Cognitive impairment in multiple sclerosis. 123
Psychosocial issue in children and adolescents with multiple sclerosis. 121
Coping strategies, cognitive impairment, psychological variables and their relationship with quality of life in multiple sclerosis. 121
Brain metabolic changes suggestive of axonal damage in radiologically isolated syndrome. 121
Aging process, adherence to Mediterranean diet and nutritional status in a large cohort of nonagenarians: Effects on endothelial progenitor cells 121
NEOCORTICAL VOLUME DECREASE IN RELAPSING-REMITTING MULTIPLE SCLEROSIS WITH MILD COGNITIVE IMPAIRMENT. 120
Association of Neocortical Volume Changes with Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis 120
Are there protective treatments for cognitive decline in MS? 119
Withdrawal of fingolimod treatment for relapsing-remitting multiple sclerosis: report of six cases. 118
Cognitive changes in multiple sclerosis 116
RESPONSE TO INTERFERON-BETA THERAPY IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: A COMPARISON OF DIFFERENT CLINICAL CRITERIA. 115
Multiple sclerosis-related cognitive changes: a review of cross-sectional and longitudinal studies. 115
Emotional and neutral verbal memory impairment in Multiple Sclerosis. 115
Switching to second-line therapies in interferon- beta treated relapsing-remitting multiple sclerosis patients 114
Prognostic role of intrathecal IgM synthesis in multiple sclerosis: Results from a clinical series 114
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs. 114
Posterior brain damage and cognitive impairment in pediatric multiple sclerosis. 113
Prognostic value of post-acute EEG in severe disorders of consciousness, using American Clinical Neurophysiology Society terminology 113
ApolipoproteinE epsilon 4 allele is not associated with disease course and severity in multiple sclerosis. 112
Cognitive and psychosocial features of childhood and juvenile MS. 112
Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient. 112
New natural history of interferon-b treated relapsing multiple sclerosis 111
Subclinical MS. Follow-up of four cases 111
No association between chronic cerebrospinal venous insufficiency and pediatric-onset multiple sclerosis. 111
Breastfeeding is not related to postpartum relapses in multiple sclerosis. 110
Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta 110
Safety and tolerability of cyclophosphamide 'pulses' in multiple sclerosis: a prospective study in a clinical cohort. 107
Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis. 106
The brief neuropsychological battery for children: a screening tool for cognitive impairment in childhood and juvenile multiple sclerosis. 103
The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis 102
Author response: Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks 102
Intravenous mitoxantrone and cyclophosphamide as second-line therapy in multiple sclerosis: an open-label comparative study of efficacy and safety. 101
Neocortical volume decrease in relapsing-remitting MS patients with mild cognitive impairment. 101
Clinical outcome measures in multiple sclerosis 101
Interobserver agreement on Poser's and the new McDonald's diagnostic criteria for multiple sclerosis. 100
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis 100
BENIGN MULTIPLE SCLEROSIS: COGNITIVE, PSYCHOLOGICAL AND SOCIAL ASPECTS IN A CLINICAL COHORT. 100
Coping strategies, psychological variables and their relationship with quality of life in multiple sclerosis. 99
Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis 99
Reliability, practice effects, and change indices for Rao's Brief Repeatable Battery. 99
Gray matter atrophy cannot be fully explained by white matter damage in patients with MS 99
The contribution of cerebrospinal fluid oligoclonal band sto the early diagnosis of multiple sclerosis 98
Cortical lesions in radiologically isolated syndrome 98
Cognitive impairment in pediatric multiple sclerosis. 98
Autologous hematopoietic stem cell transplantation for very active relapsing-remitting multiple sclerosis: report of two cases. 97
Cognitive impairment predicts conversion to multiple sclerosis in clinically isolated syndromes. 97
Maturational Trajectory of Processing Speed Performance in Pediatric Multiple Sclerosis 97
EEG and Coma Recovery Scale-revised prediction of neurological outcome in Disorder of Consciousness patients 96
Fertility, pregnancy and childbirth in patients with multiple sclerosis: impact of disease-modifying drugs. 96
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: I: Fetal risks 95
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks 95
Long-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosis 93
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis. 93
CMV AND EBV REACTIVATION AFTER AUTOLOGOUS HAEMOPOIETIC STEM CELL TRANSPLANTATION WITH BEAM CONDITIONING REGIMEN FOR MULTIPLE SCLEROSIS AND LYMPHOMA: A RETROSPECTIVE SINGLE CENTER CASE-CONTROL STUDY 93
Breastfeeding and post-partum relapses in multiple sclerosis patients 92
Experience with rituximab therapy in a real-life sample of multiple sclerosis patients 91
Cognitive reserve is a determinant of social and occupational attainment in patients with pediatric and adult onset multiple sclerosis 91
Clinical correlations of CSF single IgG bands. 91
Immunomodulatory therapies delay disease progression in multiple sclerosis. 89
Multiple sclerosis in Italy: cost-of-illness study. 88
Post-marketing of disease modifying drugs in multiple sclerosis: an exploratory analysis of gender effect in interferon beta treatment. 88
Fatigue and its relationships with cognitive functioning anddepression in paediatric multiple sclerosis. 88
Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study. 87
HSCT for severe multiple sclerosis with BEAM/ATG: impact on female fertility 86
Totale 12.951
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.351
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.351
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.846 0 0 0 0 0 367 328 359 305 214 216 57
2020/20211.577 136 151 141 155 48 205 86 120 141 203 81 110
2021/20221.032 41 110 89 31 31 42 61 62 52 41 210 262
2022/20232.605 259 589 119 159 176 433 341 136 261 13 74 45
2023/20241.026 53 103 164 84 92 76 48 182 17 68 98 41
2024/20255.156 267 719 378 993 1.944 855 0 0 0 0 0 0
Totale 16.729